2022
Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia
Pettigrew MM, Kwon J, Gent JF, Kong Y, Wade M, Williams DJ, Creech CB, Evans S, Pan Q, Walter EB, Martin JM, Gerber JS, Newland JG, Hofto ME, Staat MA, Fowler VG, Chambers HF, Huskins WC. Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia. MBio 2022, 13: e00195-22. PMID: 35323040, PMCID: PMC9040816, DOI: 10.1128/mbio.00195-22.Peer-Reviewed Original ResearchConceptsCommunity-acquired pneumoniaShort-course strategyBeta-lactam therapyTreatment strategiesAntibiotic useRespiratory microbiomePediatric community-acquired pneumoniaDays of antibioticsShorter antibiotic coursesStandard-strategy groupDays of therapyStandard treatment strategyAntibiotic resistanceAdditional rationaleEffectiveness of interventionsImpact of durationAntibiotic coursesThroat swabsCourse strategyAntibiotic treatmentPediatric pneumoniaCourse treatmentLow prevalencePneumoniaAntibiotic resistance determinants
2017
Panel 4: Report of the Microbiology Panel
Barenkamp SJ, Chonmaitree T, Hakansson AP, Heikkinen T, King S, Nokso‐Koivisto J, Novotny LA, Patel JA, Pettigrew M, Swords WE. Panel 4: Report of the Microbiology Panel. Otolaryngology 2017, 156: s51-s62. PMID: 28372529, PMCID: PMC5490388, DOI: 10.1177/0194599816639028.Peer-Reviewed Original ResearchConceptsOtitis mediaUpper respiratory tract infectionRespiratory tract infectionsAcute otitis mediaOtitis media casesRespiratory syncytial virusFuture treatment optionsTract infectionsBacterial coinfectionBacterial virulence determinantsBasic laboratory studiesSyncytial virusTreatment optionsAntibiotic treatmentEpidemiology of diseaseAnimal modelsPanel membersClinical practicePubMed databaseNational HarborVirulence determinantsChildrenInitial reviewBacteriologyDraft reviews